NFE2L2 and lymphoma: Above all, we may conclude that EBV-LMP1 promotes the level of cell autophagy after DDP treatment by activating the MEK1/2/Nrf-2 signaling pathway in lymphoma cells, thus, enhancing the resistance of lymphoma cells to DDP.